LB Pharmaceuticals Inc Common Stock reports a Return on Equity (ROE) of -10.34%.

What is LBRX's dividend yield?

LB Pharmaceuticals Inc Common Stock offers a dividend yield of 0.00%.

What is LBRX's Quality Score?

Our AI rates LBRX's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy LBRX?

Our AI Timing Score for LBRX is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does LBRX belong to?

LB Pharmaceuticals Inc Common Stock is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

LB Pharmaceuticals Inc (LBRX) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

LBRX AI Analysis Summary

Our AI summary for LBRX: LB Pharmaceuticals Inc Common Stock (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -10.34%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

LBRX

LB Pharmaceuticals Inc Common Stock

US:NASDAQ STOCK Healthcare >> Biotechnology News 98

USD 45.00

2.16 (5.04%) Day Change

Watchlist Portfolio Compare Chart

0.00

D/E

-10.3%

ROE

-10.0%

ROA

0.00%

Div Yield

LB PHARMACEUTICALS INC COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 45.00 Price 2.16 (5.04%) Day Change	NEWS SCORE: 98

LBRX, the overall quality is not quite good ( Quality = 54) but the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

47%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	45.00
PBV / Sector	3.24 / 44,022.72
Earning Per Share	-1.43

PE / Sector	N/A / 19.17
PEG or PE/Growth / Sector	N/A / 1.24
Average 1M Daily Value	13.19 M GREAT
Average 1W Daily Value	24.92 M GREAT

Timing Factors

85%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.24
NPM Average (%) / Sector	N/A / -1,697.63
NPM Change Average (%) / Sector	N/A / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-9.95 / 185,260.96
ROA Average (%) / Sector	-57.34 / 36,684.70
ROA Change Average (%) / Sector	279.40 / 422,221.66 GREAT
ROE (%) / Sector	-10.34 / 243,762.23
ROE Average (%) / Sector	23.21 / 48,758.47 GOOD
ROE Change Average (%) / Sector	28.57 / 424,968.10 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.49

Registration Details

Analyze Date	2026-08-05 08:00:28
Symbol	LBRX
Name	LB PHARMACEUTICALS INC COMMON STOCK
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	28.68 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,228.51 / 9,586.08

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: One Pennsylvania Plaza, New York, NY, United States, 10119

Phone: 212 605 0300

Website: https://lbpharma.us

Sector: Healthcare >> Biotechnology

Description: LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.